What is the ticker symbol for Alimera Sciences?

Alimera Sciences trades under the ticker ALIM on NASDAQ.

What sector does Alimera Sciences operate in?

Alimera Sciences is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze ALIM in a portfolio?

PortView shows ALIM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Alimera Sciences (ALIM) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$5.54-0.18%

1-year price historyRange $2.63 – $5.60

52-week range$5.54

$2.61$5.65

What Alimera Sciences does

Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.

Key metrics

Market cap

$301.29M

P/E (TTM)

5.28

EPS (TTM)

$1.05

Beta

1.25

Dividend yield

0.00%

Revenue / share

$3.16

50-day avg

$5.56

200-day avg

$4.17

52-week high

$5.65

52-week low

$2.61

CEO

Richard S. Eiswirth Jr.

ETFs linked to ALIM

Broad-market and Healthcare sector ETFs an investor holding Alimera Sciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ALIM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALIM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Alimera Sciences?: Alimera Sciences trades under the ticker ALIM on NASDAQ.
Which exchange is ALIM listed on?: ALIM is listed on NASDAQ.
What sector does Alimera Sciences operate in?: Alimera Sciences is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze ALIM in a portfolio?: PortView shows ALIM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.